Inventor · disambiguated record
Norbert Pardi
Also filed as: PARDI NORBERT
4 granted patents·11 pending applications·4 citations·filing 2016–2025
64Inventor score
Top patents by PatentIndex Score
15 records- 0187US11241490B2Nucleoside-modified RNA for inducing an immune response against zika virusUNIV PENNSYLVANIA·Filed 2018·Granted Feb 8, 2022·4 cites·16 claims
- 0284US2025064914A1Nucleoside-modified RNA for Inducing an Adaptive Immune ResponseUNIV PENNSYLVANIA·Filed 2024·Application pending·0 cites
- 0380US2025049909A1Compositions for Inducing an Immune Response Against Zika VirusUNIV PENNSYLVANIA·Filed 2024·Application pending·0 cites
- 0477US12138305B2Nucleoside-modified RNA for inducing an adaptive immune responseUNIV PENNSYLVANIA·Filed 2022·Granted Nov 12, 2024·0 cites·13 claims
- 0575US12161709B2Compositions for inducing an immune response against zika virusUNIV PENNSYLVANIA·Filed 2021·Granted Dec 10, 2024·0 cites·23 claims
- 0671US12371666B2Nucleoside modified mRNA and uses thereofBOSTON MEDICAL CT CORP·Filed 2022·Granted Jul 29, 2025·0 cites·22 claims
- 0771US2022040285A1Nucleoside-Modified RNA For Inducing an Adaptive Immune ResponseUNIV PENNSYLVANIA·Filed 2021·Application pending·0 cites
- 0866US2025313806A1Nucleoside modified mrna and uses thereofBOSTON MEDICAL CT CORP·Filed 2025·Application pending·0 cites
- 0961US2018303925A1Nucleoside-Modified RNA For Inducing an Adaptive Immune ResponseUNIV PENNSYLVANIA·Filed 2016·Application pending·0 cites
- 1060US2025120997A1Intraspinal delivery of therapeutic agentsUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 1156US2023248818A1Nucleoside-modified RNA for Inducing an Immune Response Against SARS-CoV-2UNIV PENNSYLVANIA·Filed 2021·Application pending·0 cites
- 1255US2023233706A1In vivo targeting of CD4+-T cells for mRNA therapeuticsUNIV PENNSYLVANIA·Filed 2021·Application pending·0 cites
- 1351US2023181715A1Universal Influenza Vaccine Using Nucleoside-Modified mRNANACHBAGAUER RAFFAEL·Filed 2021·Application pending·0 cites
- 1451US2023129061A1The use of growth factor-encoding nucleoside-modified mRNA for periodontal tissue regenerationUNIV PENNSYLVANIA·Filed 2021·Application pending·0 cites
- 1545US2019274968A1Nucleoside-modified rna for inducing an adaptive immune responseUNIV PENNSYLVANIA·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Norbert Pardi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →